News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
670,892 Results
Type
Article (50074)
Company Profile (231)
Press Release (620587)
Multimedia
Podcasts (127)
Webinars (19)
Section
Business (190039)
Career Advice (2668)
Deals (34405)
Drug Delivery (124)
Drug Development (81873)
Employer Resources (165)
FDA (16854)
Job Trends (14280)
News (332426)
Policy (33893)
Tag
Academia (2543)
Academic (1)
Accelerated approval (12)
Adcomms (32)
Allergies (97)
Alliances (47428)
ALS (116)
Alzheimer's disease (1544)
Antibody-drug conjugate (ADC) (183)
Approvals (16806)
Artificial intelligence (350)
Autoimmune disease (36)
Automation (15)
Bankruptcy (344)
Best Places to Work (10644)
BIOSECURE Act (22)
Biosimilars (136)
Biotechnology (120)
Bladder cancer (98)
Brain cancer (38)
Breast cancer (370)
Cancer (2950)
Cardiovascular disease (236)
Career advice (2226)
Career pathing (34)
CAR-T (190)
CDC (41)
Cell therapy (529)
Cervical cancer (23)
Clinical research (67405)
Collaboration (1033)
Company closure (3)
Compensation (706)
Complete response letters (33)
COVID-19 (2741)
CRISPR (61)
C-suite (342)
Cystic fibrosis (117)
Data (3006)
Decentralized trials (2)
Denatured (33)
Depression (74)
Diabetes (358)
Diagnostics (6004)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (151)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (135)
Earnings (77340)
Editorial (48)
Employer branding (20)
Employer resources (149)
Events (102532)
Executive appointments (858)
FDA (18549)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (914)
Gene editing (135)
Generative AI (28)
Gene therapy (411)
GLP-1 (913)
Government (4386)
Grass and pollen (6)
Guidances (177)
Healthcare (17180)
HIV (44)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (183)
Immuno-oncology (11)
Indications (40)
Infectious disease (2929)
Inflammatory bowel disease (155)
Inflation Reduction Act (11)
Influenza (65)
Intellectual property (121)
Interviews (482)
IPO (16102)
IRA (53)
Job creations (4016)
Job search strategy (1864)
Kidney cancer (14)
Labor market (49)
Layoffs (565)
Leadership (26)
Legal (8320)
Liver cancer (83)
Longevity (12)
Lung cancer (411)
Lymphoma (215)
Machine learning (11)
Management (58)
Manufacturing (420)
MASH (98)
Medical device (12485)
Medtech (12489)
Mergers & acquisitions (19033)
Metabolic disorders (941)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (136)
Neuropsychiatric disorders (41)
Neuroscience (2271)
NextGen: Class of 2025 (5878)
Non-profit (3739)
Now hiring (41)
Obesity (493)
Opinion (280)
Ovarian cancer (96)
Pain (119)
Pancreatic cancer (120)
Parkinson's disease (194)
Partnered (21)
Patents (314)
Patient recruitment (165)
Peanut (51)
People (56398)
Pharmaceutical (90)
Pharmacy benefit managers (25)
Phase I (20741)
Phase II (29317)
Phase III (22673)
Pipeline (1691)
Policy (241)
Postmarket research (2807)
Preclinical (8619)
Press Release (61)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (259)
Rare diseases (513)
Real estate (5767)
Recruiting (67)
Regulatory (23877)
Reports (38)
Research institute (2330)
Resumes & cover letters (440)
Rett syndrome (10)
RNA editing (8)
RSV (55)
Schizophrenia (98)
Series A (162)
Series B (108)
Service/supplier (17)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (36)
Startups (3490)
State (2)
Stomach cancer (17)
Supply chain (81)
Tariffs (65)
The Weekly (92)
Vaccines (893)
Venture capital (57)
Weight loss (332)
Women's health (46)
Worklife (20)
Date
Today (79)
Last 7 days (364)
Last 30 days (1899)
Last 365 days (31524)
2025 (17249)
2024 (34940)
2023 (39132)
2022 (50081)
2021 (54091)
2020 (51694)
2019 (42875)
2018 (32750)
2017 (32517)
2016 (31563)
2015 (35660)
2014 (29174)
2013 (24460)
2012 (26480)
2011 (27240)
2010 (25334)
Location
Africa (815)
Alabama (64)
Alaska (7)
Arizona (212)
Arkansas (12)
Asia (41684)
Australia (6668)
California (7273)
Canada (2224)
China (696)
Colorado (312)
Connecticut (336)
Delaware (200)
Europe (94128)
Florida (1109)
Georgia (246)
Hawaii (2)
Idaho (50)
Illinois (612)
India (29)
Indiana (348)
Iowa (18)
Japan (234)
Kansas (96)
Kentucky (27)
Louisiana (13)
Maine (68)
Maryland (1036)
Massachusetts (5546)
Michigan (219)
Minnesota (421)
Mississippi (2)
Missouri (88)
Montana (27)
Nebraska (23)
Nevada (76)
New Hampshire (63)
New Jersey (2084)
New Mexico (29)
New York (2046)
North Carolina (1126)
North Dakota (7)
Northern California (3216)
Ohio (213)
Oklahoma (12)
Oregon (32)
Pennsylvania (1550)
Puerto Rico (18)
Rhode Island (35)
South America (1208)
South Carolina (33)
South Dakota (1)
Southern California (2731)
Tennessee (117)
Texas (1085)
United States (27134)
Utah (196)
Virginia (189)
Washington D.C. (75)
Washington State (620)
West Virginia (4)
Wisconsin (72)
670,892 Results for "covis pharma holdings s a r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
March 17, 2025
·
4 min read
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Tariffs
Trump’s Tariffs Could Challenge Pharma’s Recession-Resistant Reputation
Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as GLP-1s dominate and the population grows older.
April 8, 2025
·
5 min read
·
Annalee Armstrong
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Business
TIGIT Turmoil: How Pharma Burned Billions on Failed Immuno-Oncology Projects
Leading companies spent $1.4 billion upfront on licensing deals and embarked on vast R&D programs. Clinical setbacks mean many companies are unlikely to ever recoup their investments.
June 25, 2025
·
5 min read
·
Nick Paul Taylor
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
June 6, 2025
·
2 min read
Press Releases
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 4, 2025
·
3 min read
1 of 67,090
Next
